0000899243-17-014034.txt : 20170522 0000899243-17-014034.hdr.sgml : 20170522 20170522161017 ACCESSION NUMBER: 0000899243-17-014034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170518 FILED AS OF DATE: 20170522 DATE AS OF CHANGE: 20170522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSS MICHAEL JAY CENTRAL INDEX KEY: 0001254452 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 17860993 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-18 0 0001410939 Ophthotech Corp. OPHT 0001254452 ROSS MICHAEL JAY ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 1 0 0 0 Common Stock 2017-05-18 4 M 0 1750 A 3500 D Restricted Stock Units 2017-05-18 4 M 0 1750 0.00 D Common Stock 1750 0 D Stock Option (right to buy) 2.46 2017-05-19 4 A 0 16000 0.00 A 2017-06-19 2027-05-18 Common Stock 16000 16000 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. As previously reported, on June 2, 2016 the Issuer awarded the Reporting Person a Restricted Stock Unit award which represented the contingent right to receive 1,750 shares of Issuer common stock. Pursuant to the terms of a Restricted Stock Unit Agreement by and between the Reporting Person and the Issuer, this Restricted Stock Unit award vested on May 18, 2017 with respect to 100% of the shares subject to the award, and the shares were issued to the Reporting Person. Subject to Reporting Person providing continued services to the Issuer and other terms and conditions under a stock option agreement by and between the Reporting Person and the Issuer, The option will vest and become exercisable in 12 consecutive, equal monthly installments commencing on June 19, 2017 until fully vested and exercisable on the first anniversary of the date of grant. Any unvested shares subject to the option will be accelerated in full one business day prior to the Issuer's 2018 annual meeting of stockholders. /s/ Thomas B. Rosedale (Pursuant to Power of Attorney) 2017-05-22